DNDN Stock UPDATES Dendreon Corp (DNDN) 1.10 10/21/2014 23:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Dendreon Corp (DNDN) 1.10 $DNDN

The 1 Biotech Stock I'm Definitely Not Buying
Motley Fool Staff - Motley Fool - Tue Oct 07, 7:35AM CDT
Biotechnology stocks are notorious for roller-coaster like highs and lows, but that doesn't mean that every biotech that heads lower will climb again. Figuring out which companies are bargains and which aren't can be particularly tough in this...
DNDN: 1.10 (-0.03), AEGR: 32.13 (+0.21), ARNA: 4.16 (-0.01)

Cheap Stocks Wall Street Loves: Medivation
Sean Williams, The Motley Fool - Motley Fool - Mon Oct 06, 10:11AM CDT
To say that Wall Street and investors are in love with biopharmaceutical cancer-focused company Medivation would be a dramatic understatement. Over the trailing-three-year period shares of Medivation have galloped higher by better than 1,000%! ...
MDVN: 96.97 (+1.99), JNJ: 100.36 (+1.16), DNDN: 1.10 (-0.03)

Micro-Cap Biotechs: The Next Billion Dollar Drug Is Coming From...?
OptionVol - Thu Oct 02, 5:33PM CDT
This visualization is provided by: Capital Market Laboratories (join the queue: free trial) Micro Cap Bio-techs: Who's Investing in R&D? Note that the firms above the blue line I've drawn in are pouring in at least $0.60 into researc...
LOXO: 11.30 (+0.13), DNDN: 1.10 (-0.03), VNDA: 10.19 (-0.37), OSIR: 13.01 (+0.09), CLDN: 10.31 (+0.49), GALE: 1.92 (+0.09), CTIC: 2.37 (-0.02), OTIC: 23.71 (+0.97)

Why Northwest Biotherapeutics Inc. Stock Skyrocketed 36% in 2014
Sean Williams, The Motley Fool - Motley Fool - Fri Sep 26, 9:10AM CDT
The stock market as a whole may have swooned over the past couple of days, but that hasn't changed the fact that the broad-based S&P 500 , as well as the SPDR S&P Biotech ETF , are up notably year to date. In fact, the aforementioned...
NWBO: 5.09 (+0.25), DNDN: 1.10 (-0.03)

Dendreon (DNDN) in Focus: Stock Up 9.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 16, 7:44AM CDT
Dendreon Corp. (DNDN) was a big mover last session, as the company saw its shares rise over 9% on the day
CBM: 17.88 (+0.14), HSKA: 12.16 (-0.24), DNDN: 1.10 (-0.03), ILMN: 179.55 (+15.08)

VG, NOA, RGDX, BOFI, DSCI, DNDN Are Seasonally Ripe To Go Down In the Next Five Weeks
M2 - Mon Sep 15, 4:16AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Vonage Holdings Corp (NYSE:VG), North American Energy Partners Inc (NYSE:NOA), Response Genetics Inc (NASDAQ:RGDX), BofI Holding Inc (NASDAQ:BOFI), Derma Sciences Inc (NASDAQ SCI), Dendreon Corp (NASDAQ NDN) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
DSCI: 8.86 (-0.08), BOFI: 70.38 (+1.66), NOA: 5.83 (+0.31), DNDN: 1.10 (-0.03), RGDX: 0.59 (+0.05), VG: 3.32 (+0.09)

Why Inovio Pharmaceuticals Inc. Plunged By 10% in 2014
Sean Williams, The Motley Fool - Motley Fool - Fri Sep 12, 9:10AM CDT
The biotech sector, perhaps more than any other sector, is a breeding ground for large stock moves. This is because biotech stocks are predominantly valued based on their future sales potential as well as Wall Street forecasts for how many people...
INO: 11.55 (-0.64), DNDN: 1.10 (-0.03)

Technical Coverage on Biotech Stocks - Exelixis, Arena Pharma, Novavax, Dendreon, and Amicus Therapeutics
PR Newswire - Fri Sep 12, 7:40AM CDT
On Thursday, September 11, 2014, the NASDAQ Composite ended at 4,591.81, up 0.12%, the Dow Jones Industrial Average finished the day 0.12% lower at 17,049.00, and the S&P 500 closed at 1,997.45, up 0.09%. The gains were broad based as seven out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 741.83, down 0.33%, while the index has advanced 5.97% in the last one month. Investor-Edge has initiated coverage on the following equities: Exelixis Inc. (NASDAQ: EXEL), Arena Pharmaceuticals Inc. (NASDAQ: ARNA), Novavax Inc. (NASDAQ: NVAX), Dendreon Corporation (NASDAQ: DNDN), and Amicus Therapeutics Inc. (NASDAQ: FOLD). Free research on these five companies can be accessed at:
NVAX: 4.99 (-0.02), DNDN: 1.10 (-0.03), ARNA: 4.16 (-0.01), FOLD: 5.82 (-0.12), EXEL: 1.60 (-0.05)

Medivation Eyes Blockbuster As Cancer Drug Gets An OK
at Investor's Business Daily - Thu Sep 11, 4:41PM CDT
Two years ago, biotech Medivation launched its first drug -- an achievement that put it ahead of more than half the biotechs trading on the market. But as of Wednesday afternoon, as far as Wall Street was concerned, it became more than just another...
MDVN: 96.97 (+1.99), JNJ: 100.36 (+1.16), GILD: 106.67 (+4.46), DNDN: 1.10 (-0.03), AMGN: 144.09 (+6.58)

Medivation Inc's FDA Approval Could be the Deathblow for Johnson & Johnson's Blockbuster Prostate Ca
Brian Orelli, The Motley Fool - Motley Fool - Wed Sep 10, 8:42PM CDT
Johnson & Johnson 's sold over $1 billion worth of its prostate cancer drug Zytiga in the first half of the year, putting it on pace to be a blockbuster two times over . But not if Medivation and partner Astellas Pharma have anything to...
MDVN: 96.97 (+1.99), JNJ: 100.36 (+1.16), DNDN: 1.10 (-0.03)

Global Cancer Vaccines Market & Pipeline Analysis Report 2014: 12 Marketed Vaccines & 289 Pipeline Vaccines
M2 - Mon Sep 08, 10:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nnd4k6/global_cancer) has announced the addition of the "Global Cancer Vaccines Market & Pipeline Analysis" report to their offering. Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. Therapeutic or Treatment vaccines are targeted at treating an existing cancer by strengthening the body's natural defences against the cancer and the Prophylactic or Preventive vaccines are used to prevent cancer from developing in healthy people. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer. With the increasing focus of pharmaceutical companies in the cancer vaccine segment, the prophylactic vaccines segment grew substantially and currently is the largest source of revenue, with the therapeutic vaccines segment still remaining untapped. It is most likely that the regulatory authorities would in the near future quicken its approval process specifically for therapeutic vaccines. This coupled with a significant amount of investment for the research and development of these vaccines by the pharmaceutical companies would certainly push the overall cancer vaccines market onto a rapid growth trajectory. The current market size of cancer vaccines category is many fold smaller than other cancer therapeutics categories. Due to nascent stages of industry-life cycle and late introduction in market has decreased their overall share. To tap this cancer market category, many global companies are actively investing in cancer vaccine development. The market penetration is expected to increase with the competition among various pharmaceutical companies to get a larger portion of this market category. Global Cancer Vaccines Market & Pipeline Analysis" Report Highlights: - Global Cancer Market Overview - Personalized Cancer Vaccines: Progress & Possibilities - Platforms for Cancer Vaccines Delivery - Cancer Vaccines: Mechanism & Innovations - Global Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country - Global Cancer Vaccine Clinical Pipeline: 289 Vaccines - Marketed Cancer Vaccines: 12 Vaccines - Regulatory Framework for Cancer Vaccines Development & Marketing Key Topics Covered: 1. Introduction to Cancer Vaccines 2. Cancer Vaccines: Mechanism & Innovations 3. Adjuvants Platforms for Cancer Vaccines Delivery 4. Global Cancer Vaccines Market Overview 5. Personalized Cancer Vaccines: Progress & Possibilities 6. Public HPV Cancer Vaccination Program 7. Global Cancer Vaccines Market Dynamics 8. Future Prospects of Cancer Vaccines 9. Global Cancer Vaccines Clinical Pipeline Insight by Phase, Indication, Company & Country 10. Marketed Cancer Vaccines Clinical Insight by Indication, Company & Country 11. Suspended & Discontinued Cancer Vaccines Clinical Pipeline by Phase, Indication, Company & Country 12. FDA Regulatory Framework for Cancer Vaccines Development & Marketing 13. Competitive Landscape: Business Overview & Product Pipeline - Advaxis - Celldex Therapeutics - Dendreon Corporation - Galena Biopharma - ImmunoCellular Therapeutics - ImmunoGen - Inovio Pharmaceuticals - Merck - NeoStem Oncology - NewLink Genetics - Northwest Biotherapeutics - Novartis - Peregrine Pharmaceuticals - Roche - Seattle Genetics For more information visit http://www.researchandmarkets.com/research/nn...bal_cancer
NWBO: 5.09 (+0.25), MRK: 55.13 (+1.08), DNDN: 1.10 (-0.03), CLDX: 14.74 (-0.41), NLNK: 34.50 (+3.06), GALE: 1.92 (+0.09), IMUC: 0.71 (-0.01), NVS: 88.61 (+0.71)

SPDR(R) S&P Biotech ETF Receives Settlement Payment
Business Wire - Mon Aug 18, 3:00PM CDT
State Street Global Advisors announced today that the SPDR(R) S&P Biotech ETF (NYSE: XBI- News) received payment as an authorized claimant from a class action settlement related to Dendreon, Corp.
STT: 68.97 (+1.55), DNDN: 1.10 (-0.03)

Aug. 18 Premarket Briefing: 10 Things You Should Know
at The Street - Mon Aug 18, 5:47AM CDT
U.S. stock futures rise as European stocks stage a recovery; Dollar General offers to buy Family Dollar for $9.7 billion; Tesla extends warranty on Model S sedan.
URBN: 30.24 (+0.05), TSLA: 235.34 (+4.87), DLTR: 58.13 (+0.79), DNDN: 1.10 (-0.03), TGT: 61.64 (+1.35), DG: 62.19 (+0.67), RSH: 0.97 (-0.07), FDO: 77.45 (+0.69)

Ebola Vaccine and Inhaled Insulin Incoming
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat Aug 16, 5:01AM CDT
In this healthcare-focused of episode of Where The Money Is, analysts David Williamson and Michael Douglass tackle the weeks biggest stories in pharma and biotech, and how the industry is attempting to combat the Ebola Outbreak. MannKind's big news...
DNDN: 1.10 (-0.03), GSK: 43.63 (+0.02), SNY: 52.15 (+0.37), MNKD: 5.53 (+0.17)

Dendreon Down on Default Risk, Reports Narrower Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 1:37PM CDT
Shares of Dendreon Corporation (DNDN) were down significantly after the company warned that it will not be able to repay or refinance its notes due 2016.
AGN: 186.16 (+6.91), GILD: 106.67 (+4.46), DNDN: 1.10 (-0.03)

Kate Spade and Flowers Foods are big market movers
AP - Tue Aug 12, 3:42PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
KMI: 38.31 (+0.74), EA: 35.69 (+0.76), NUAN: 14.91 (+0.07), TKMR: 17.98 (-0.63), EXAS: 24.22 (+0.36), CZR: 12.44 (+1.03), MFRM: 60.84 (+0.41), PCLN: 1,132.97 (+29.90), TKM.TO: 20.17 (-0.82), DNDN: 1.10 (-0.03), CQB: 13.24 (+0.44), ICPT: 225.71 (-5.62), DF: 13.93 (-0.11), KATE: 26.40 (+0.54), FLO: 18.81 (+0.28)

Most active Nasdaq-traded stocks
AP - Tue Aug 12, 12:48PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
MU: 31.19 (+1.50), FB: 78.69 (+1.74), TKMR: 17.98 (-0.63), INTC: 32.61 (+1.03), TKM.TO: 20.17 (-0.82), FOX: 32.54 (+0.58), DNDN: 1.10 (-0.03), FOXA: 33.67 (+0.63), MSFT: 44.88 (+0.80), ZNGA: 2.43 (+0.14), NIHD: 0.06 (-0.01), AAPL: 102.47 (+2.71), CSCO: 23.51 (+0.58)

Why Dendreon Corporation Stock Slumped Today
Michael Douglass, The Motley Fool - Motley Fool - Tue Aug 12, 9:46AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  In its latest 10-Q, filed yesterday, cancer drug...
DNDN: 1.10 (-0.03)

Why Dendreon (DNDN) Stock Hit a One-Year Low Today
at The Street - Tue Aug 12, 9:04AM CDT
Dendreon (DNDN) plunged to a 52-week low of $1.33 on Tuesday after the company warned of it may not be able to pay its debt that matures in 2016.
DNDN: 1.10 (-0.03)

Dendreon Warns Debt Bomb Might Wipe Out Shareholders
at The Street - Tue Aug 12, 6:17AM CDT
The struggling Provenge peddler is suffocating under $620 million in debt and the bill comes soon.
DNDN: 1.10 (-0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 70

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 431

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 548

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 306

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 52

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 160

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 458

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 117

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 124

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

WIC Forum Set to Transform Cultural Heritage through Digitalization

Updated Category News Views 194

WIC Forum Set to Transform Cultural Heritage through Digitalization The World Internet Conference (WIC) recently held a significant press conference to announce the upcoming Cultural Heritage Digitalization Forum. This important event aims to explore the relationship between technology and cultural heritage preservation. Event Overview The WIC's briefing included key...

Continue Reading
Nordea Bank Rectifies Errors in Exchange Traded Products

Updated Category News Views 194

Correction of Errors in Exchange Traded Products Nordea Bank Abp, acting as the issuer, has identified and decided to amend certain final terms related to instruments listed in their documentation. This corrective action is taken based on identified manifest errors that needed rectification. The bank is entitled to make such modifications under subsection (i) of Condition...

Continue Reading
NEXE Innovations 2024 Review: A New Era of Sustainability Ahead

Updated Category News Views 324

Strategic Developments at NEXE Innovations NEXE Innovations Inc. (TSXV: NEXE) is making headlines with its impressive strides toward sustainable growth. This innovative company is dedicated to developing compostable materials to meet the rising demand for eco-friendly solutions. Their focus is on high-performance products that serve various markets, creating robust...

Continue Reading
Analyzing Affiliated Managers Group's Price-to-Earnings Ratio

Updated Category News Views 144

Understanding Affiliated Managers Group's Stock Performance In today's market, Affiliated Managers Group Inc. (NYSE: AMG) is trading at $281.79, reflecting a slight increase of 0.97%. Over the last month, the stock has appreciated by 5.89%, showcasing an impressive 50.30% rise over the past year. Such robust performance invites optimism among long-term investors, although...

Continue Reading
Revolutionizing Medical Device Development Through Live Prototyping

Updated Category News Views 182

Accelerating Medical Device Innovation In the fast-evolving world of healthcare technology, the demand for speed and efficiency has never been more critical. Elevaris Medical Devices, a prominent Contract Development and Manufacturing Organization (CDMO), is at the forefront of this transformation. They specialize in working with multi-national healthcare firms, global...

Continue Reading